We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
EHC
851
Everett Harris & Co
California
$2.67M
OA
852
Outfitter Advisors
Virginia
$2.66M +$11.8K +210 +0.4%
PCMI
853
Princeton Capital Management Inc
New Jersey
$2.64M +$539K +9,600 +26%
CD
854
Carl Domino
Florida
$2.62M -$25.2K -448 -1%
GA
855
GFS Advisors
Texas
$2.62M
CCM
856
Catawba Capital Management
Virginia
$2.62M
AC
857
Alley Company
Illinois
$2.62M +$66.5K +1,185 +3%
SHA
858
Smith Hayes Advisers
Nebraska
$2.61M -$27.8K -495 -1%
GIA
859
Guyasuta Investment Advisors
Pennsylvania
$2.57M +$16.2K +288 +0.6%
TRCT
860
Tower Research Capital (TRC)
New York
$2.56M +$2.26M +40,163 +795%
AF
861
Ally Financial
Michigan
$2.55M +$2.53M +45,064 New
GCA
862
Greenwood Capital Associates
South Carolina
$2.55M +$2.53M +45,067 New
FIM
863
Freedom Investment Management
Connecticut
$2.54M +$726K +12,932 +40%
CYG
864
Clean Yield Group
Vermont
$2.49M -$41.2K -734 -2%
ICAS
865
Investors Capital Advisory Services
Massachusetts
$2.48M +$9.1K +162 +0.4%
ID
866
Integral Derivatives
New York
$2.47M -$279K -4,970 -10%
JC
867
Jacobs & Co
California
$2.47M -$5.9K -105 -0.2%
BPM
868
Bowling Portfolio Management
Ohio
$2.46M -$25.6K -456 -1%
CIA
869
Capital Investment Advisors
Georgia
$2.45M -$10.9K -195 -0.4%
NAMA
870
Nikko Asset Management Americas
New York
$2.45M +$118K +2,096 +5%
CHAM
871
Clear Harbor Asset Management
Connecticut
$2.44M +$97.1K +1,729 +4%
FA
872
FMA Advisory
Pennsylvania
$2.44M -$59.2K -1,054 -2%
VIA
873
Vantage Investment Advisors
Pennsylvania
$2.43M +$121K +2,158 +5%
SWITC
874
Stewart West Indies Trading Company
Colorado
$2.4M
RMCM
875
Reynders McVeigh Capital Management
Massachusetts
$2.4M +$47.1K +839 +2%

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.